These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12488064)

  • 1. Pentagastrin-induced sleep panic attacks: panic in the absence of elevated baseline arousal.
    Geraci M; Anderson TS; Slate-Cothren S; Post RM; McCann UD
    Biol Psychiatry; 2002 Dec; 52(12):1183-9. PubMed ID: 12488064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the 5-HT3 antagonist, ondansetron, on the behavioral and physiological effects of pentagastrin in patients with panic disorder and social phobia.
    McCann UD; Morgan CM; Geraci M; Slate SO; Murphy DL; Post RM
    Neuropsychopharmacology; 1997 Dec; 17(6):360-9. PubMed ID: 9397424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls.
    McCann UD; Slate SO; Geraci M; Roscow-Terrill D; Uhde TW
    Neuropsychopharmacology; 1997 Mar; 16(3):229-37. PubMed ID: 9138439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.
    Abelson JL; Nesse RM
    Biol Psychiatry; 1994 Jul; 36(2):73-83. PubMed ID: 7948449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL; Liberzon I; Young EA; Khan S
    Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology.
    Abelson JL; Nesse RM; Vinik AI
    Biol Psychiatry; 1994 Jul; 36(2):84-96. PubMed ID: 7524696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients.
    van Megen HJ; Westenberg HG; den Boer JA; Haigh JR; Traub M
    Psychopharmacology (Berl); 1994 Apr; 114(3):449-55. PubMed ID: 7855203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ethinyl estradiol on the panic response to the panicogenic agent pentagastrin.
    McManus K; Tait GR; Bellavance F; Le Mellédo JM
    J Affect Disord; 2001 Oct; 66(2-3):273-9. PubMed ID: 11578682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic hormone in lactate-induced panic attacks: mode of release and endocrine and pathophysiological consequences.
    Kellner M; Knaudt K; Jahn H; Holsboer F; Wiedemann K
    J Psychiatr Res; 1998; 32(1):37-48. PubMed ID: 9693999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of medroxyprogesterone pretreatment on pentagastrin-induced panic symptoms in females with panic disorder.
    Le Mellédo J; Jhangri GS; Lott P; Tait GR; McManus K; Geddes M; Chrapko W; Lara N
    Psychiatry Res; 2001 Apr; 101(3):237-42. PubMed ID: 11311926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder.
    Brawman-Mintzer O; Lydiard RB; Bradwejn J; Villarreal G; Knapp R; Emmanuel N; Ware MR; He Q; Ballenger JC
    Am J Psychiatry; 1997 May; 154(5):700-2. PubMed ID: 9137133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of time of preparation on pentagastrin-induced symptom, endocrine and cardiovascular responses.
    Khan S; Briggs H; Abelson JL
    Psychiatry Res; 2008 Mar; 158(2):141-6. PubMed ID: 18222546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin.
    Tait GR; McManus K; Bellavance F; Lara N; Chrapko W; Le Mellédo JM
    Psychoneuroendocrinology; 2002 May; 27(4):417-29. PubMed ID: 11911996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous caffeine administered to healthy males during sleep.
    Lin AS; Uhde TW; Slate SO; McCann UD
    Depress Anxiety; 1997; 5(1):21-8. PubMed ID: 9250437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers.
    McCann UD; Slate SO; Geraci M; Uhde TW
    Anxiety; 1994-1995; 1(6):258-67. PubMed ID: 9160584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of specific association between panicogenic properties of caffeine and HPA-axis activation. A placebo-controlled study of caffeine challenge in patients with panic disorder.
    Masdrakis VG; Markianos M; Oulis P
    Psychiatry Res; 2015 Sep; 229(1-2):75-81. PubMed ID: 26243374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of intravenous pentagastrin challenge to induce panic-like effects in rhesus monkeys.
    Rupniak NM; Schaffer L; Siegl P; Iversen SD
    Neuropeptides; 1993 Aug; 25(2):115-9. PubMed ID: 8413856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin-releasing hormone: a potential comparator for the panicogenic effects of pentagastrin and CCK?
    Coupland N; Malizia A; Bailey J; Nutt D
    Biol Psychiatry; 1996 Mar; 39(6):465-6. PubMed ID: 8679797
    [No Abstract]   [Full Text] [Related]  

  • 19. Panic-related responses to pentagastrin, flumazenil, and thyrotropin-releasing hormone in healthy volunteers.
    Zedkova L; Coupland NJ; Man GC; Dinsa G; Sanghera G
    Depress Anxiety; 2003; 17(2):78-87. PubMed ID: 12621596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
    Abelson JL; Khan S; Liberzon I; Young EA
    Depress Anxiety; 2007; 24(1):66-76. PubMed ID: 16845643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.